Washington News Cloud

News From Washington DC

Lloyd Roberie

Merck Seeks FDA Emergency Approval of Anti-COVID Pill

Molnupiravir, an experimental coronavirus treatment pill developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, May 17, 2021 (Merck & Co Inc/Handout via Reuters) Merck announced Monday that it has requested emergency use authorization from the Food and Drug Administration (FDA) for its experimental antiviral COVID-19 pill. The drugmaker said in a statement that…